Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Breaking & Recent News Carisma Therapeutics Inc CARM

Carisma Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on utilizing its proprietary macrophage and monocyte cell engineering platform to develop transformative immunotherapies to treat cancer and other serious diseases. It is developing a pipeline of product candidates, with an initial focus on advancing multiple ex vivo autologous and in vivo CAR-M therapies for the... see more

Recent & Breaking News (NDAQ:CARM)

SESN 6-DAY DEADLINE ALERT: Hagens Berman Encourages Sesen Bio (SESN) Investors with Significant Losses to Contact Firm's Attorneys Now, Securities Class Action Pending

Newsfile October 12, 2021

Sesen Bio Expands CMC and Clinical Teams

Business Wire October 12, 2021

SESN LAWSUIT FILED: Jakubowitz Law Pursues Claims on Behalf of Sesen Bio, Inc. Shareholders

Newsfile October 12, 2021

Sesen Deadline Alert

Newsfile October 11, 2021

SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Sesen Bio, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of October 18, 2021 - (SESN)

Newsfile October 11, 2021

SESN LAWSUIT: The Law Offices of Vincent Wong Notify Investors of a Class Action Lawsuit Involving Sesen Bio, Inc.

Newsfile October 11, 2021

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of SLQT, SESN and SAM

Accesswire October 11, 2021

SESN ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of October 18, 2021 in the Class Action Filed on Behalf of Sesen Bio, Inc. Limited Shareholders

Newsfile October 11, 2021

SESN Investors Have Opportunity to Lead Sesen Bio, Inc. Securities Fraud Lawsuit

PR Newswire October 11, 2021

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Sesen Bio, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of October 18, 2021 - SESN

Newsfile October 11, 2021

UPCOMING DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Sesen Bio, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - SESN

PR Newswire October 10, 2021

Sesen Deadline Alert

Newsfile October 10, 2021

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Sesen Bio, Inc. of Class Action Lawsuit and Upcoming Deadline - SESN

Newsfile October 9, 2021

ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages Sesen Bio, Inc. Investors with Losses Exceeding $100K to Secure Counsel Before Important October 18 Deadline in Securities Class Action - SESN

PR Newswire October 9, 2021

Sesen Update

Newsfile October 8, 2021

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of YALA, SESN and NNOX

Accesswire October 8, 2021

SESEN BIO, INC. (SESN) INVESTOR LAWSUIT FILING DEADLINE: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Sesen Bio, Inc.

Newsfile October 8, 2021

The Gross Law Firm Announces Class Actions on Behalf of Shareholders of KPLT, SESN and HYRE

Accesswire October 8, 2021

CLASS ACTION UPDATE for ATIP, SESN and WDH: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

Accesswire October 8, 2021

SESN 10-DAY DEADLINE ALERT: Hagens Berman Alerts Sesen Bio (SESN) Investor Deadline in Securities Class Action, Encourages Investors with Significant Losses to Contact Firm's Attorneys Now

Newsfile October 8, 2021